PICO Portalanswers from OpenAlex & ORCID
Michael W. Deininger
ResearcherPublications, citations & collaboration network
Michael W. Deininger is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Michael W. Deininger have?
PICO Portalindexed works
Michael W. Deininger has 863 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael W. Deininger have?
PICO Portalcitation count
Michael W. Deininger has 49,870 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Michael W. Deininger?
PICO Portalh-index
Michael W. Deininger has an h-index of 98 in OpenAlex.
What is the i10-index of Michael W. Deininger?
PICO Portali10-index
Michael W. Deininger has an i10-index of 327 in OpenAlex.
What is the ORCID of Michael W. Deininger?
PICO Portalorcid
The ORCID for Michael W. Deininger is on the source record.
What is the OpenAlex record for Michael W. Deininger?
PICO Portalopenalex
The OpenAlex for Michael W. Deininger is on the source record.
What are the most-cited papers on Michael W. Deininger?
PICO Portalmost cited works
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Andreas Hochhaus, Michele Baccarani, Richard T. Silver, CA Schiffer, Jane F. Apperley, Francisco Cervantes, R E Clark, J. E. Cortes, Michael W. Deininger, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, J. Janssen, Hagop M. Kantarjian, D. W. Kim, Richard A. Larson, J. H. Lipton, F.-X. Mahon, Jiří Mayer, Franck E. Nicolini, D Niederwieser, Fabrizio Pane, Jerald P. Radich, Delphine Réa, Johan Richter, G Rosti, Philipe Rousselot, Giuseppe Saglio, Susanne Saußele, Simona Soverini, J. L. Steegmann, Anna Turkina, Andrey Zaritskey, R. Hehlmann
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, R. S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, E. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Azra Raza, Kris Vaddi, William Sun, Wei Peng, V. Sandor, Hagop M. Kantarjian, For the COMFORT-I investigators
Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
Jerald P. Radich, Michael W. Deininger, Camille N. Abboud, Jessica K. Altman, Ellin Berman, Ravi Bhatia, Bhavana Bhatnagar, Peter Curtin, Daniel J. DeAngelo, Jason Gotlib, Gabriela Hobbs, Madan Jagasia, Hagop M. Kantarjian, Lori J. Maness, Leland Metheny, Joseph O. Moore, Arnel Pallera, Philip Pancari, Mrinal M. Patnaik, Enkhtsetseg Purev, Michal G. Rose, Neil P. Shah, B. Douglas Smith, David S. Snyder, Kendra Sweet, Moshe Talpaz, James E. Thompson, David T. Yang, Kristina M. Gregory, Hema Sundar
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Michael W. Deininger, Neil P. Shah, Jessica K. Altman, Ellin Berman, Ravi Bhatia, Bhavana Bhatnagar, Daniel J. DeAngelo, Jason Gotlib, Gabriela Hobbs, Lori J. Maness, Monica Mead, Leland Metheny, Sanjay Mohan, Joseph O. Moore, Kiran Naqvi, Vivian G. Oehler, Arnel Pallera, Mrinal M. Patnaik, Keith W. Pratz, Iskra Pusic, Michal G. Rose, B. Douglas Smith, David S. Snyder, Kendra Sweet, Moshe Talpaz, James E. Thompson, David T. Yang, Kristina M. Gregory, Hema Sundar